Trial Profile
Botulinum toxin A in patients with Raynaud's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Raynaud's disease
- Focus Therapeutic Use
- 01 Apr 2014 Primary endpoint 'Temperature' has been met.
- 01 Apr 2014 New trial record